Ergomed plc

AIM:ERGO Stock Report

Market Cap: UK£701.1m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Ergomed Future Growth

Future criteria checks 3/6

Ergomed is forecast to grow earnings and revenue by 14.2% and 8.8% per annum respectively. EPS is expected to grow by 13.7% per annum. Return on equity is forecast to be 19.3% in 3 years.

Key information

14.2%

Earnings growth rate

13.73%

EPS growth rate

Life Sciences earnings growth51.0%
Revenue growth rate8.8%
Future return on equity19.30%
Analyst coverage

Good

Last updated13 Nov 2023

Recent future growth updates

Recent updates

Analysis Article • Aug 19

Is It Time To Consider Buying Ergomed plc (LON:ERGO)?

Ergomed plc ( LON:ERGO ), might not be a large cap stock, but it saw a double-digit share price rise of over 10% in the...
Analysis Article • Apr 12

At UK£9.74, Is Ergomed plc (LON:ERGO) Worth Looking At Closely?

While Ergomed plc ( LON:ERGO ) might not be the most widely known stock at the moment, it saw significant share price...
Analysis Article • Oct 29

Ergomed plc (LON:ERGO) Shares Could Be 21% Below Their Intrinsic Value Estimate

Does the October share price for Ergomed plc ( LON:ERGO ) reflect what it's really worth? Today, we will estimate the...
Analysis Article • Jul 14

Should You Be Adding Ergomed (LON:ERGO) To Your Watchlist Today?

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...
Analysis Article • Jun 12

Why Ergomed plc (LON:ERGO) Could Be Worth Watching

Ergomed plc ( LON:ERGO ), is not the largest company out there, but it saw significant share price movement during...
Analysis Article • Apr 07

Calculating The Fair Value Of Ergomed plc (LON:ERGO)

Does the April share price for Ergomed plc ( LON:ERGO ) reflect what it's really worth? Today, we will estimate the...
Analysis Article • Mar 19

Does Ergomed (LON:ERGO) Deserve A Spot On Your Watchlist?

Some have more dollars than sense, they say, so even companies that have no revenue, no profit, and a record of falling...
Analysis Article • Mar 01

Why Ergomed plc (LON:ERGO) Could Be Worth Watching

While Ergomed plc ( LON:ERGO ) might not be the most widely known stock at the moment, it saw a decent share price...
Analysis Article • Dec 15

Calculating The Fair Value Of Ergomed plc (LON:ERGO)

How far off is Ergomed plc ( LON:ERGO ) from its intrinsic value? Using the most recent financial data, we'll take a...
Analysis Article • Nov 24

I Ran A Stock Scan For Earnings Growth And Ergomed (LON:ERGO) Passed With Ease

Like a puppy chasing its tail, some new investors often chase 'the next big thing', even if that means buying 'story...
Analysis Article • Aug 28

Calculating The Intrinsic Value Of Ergomed plc (LON:ERGO)

In this article we are going to estimate the intrinsic value of Ergomed plc ( LON:ERGO ) by taking the forecast future...
Analysis Article • Jul 31

If You Like EPS Growth Then Check Out Ergomed (LON:ERGO) Before It's Too Late

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...
Analysis Article • Jul 06

Getting In Cheap On Ergomed plc (LON:ERGO) Might Be Difficult

Ergomed plc's ( LON:ERGO ) price-to-earnings (or "P/E") ratio of 57.4x might make it look like a strong sell right now...
Analysis Article • May 21

Ergomed plc (LON:ERGO) Shares Could Be 31% Above Their Intrinsic Value Estimate

In this article we are going to estimate the intrinsic value of Ergomed plc ( LON:ERGO ) by taking the forecast future...
Analysis Article • Mar 26

Do Ergomed's (LON:ERGO) Earnings Warrant Your Attention?

Some have more dollars than sense, they say, so even companies that have no revenue, no profit, and a record of falling...
Analysis Article • Feb 22

If You Had Bought Ergomed (LON:ERGO) Stock Five Years Ago, You Could Pocket A 643% Gain Today

We think all investors should try to buy and hold high quality multi-year winners. While the best companies are hard to...
Analysis Article • Jan 18

Has Ergomed plc's (LON:ERGO) Impressive Stock Performance Got Anything to Do With Its Fundamentals?

Ergomed's (LON:ERGO) stock is up by a considerable 23% over the past three months. As most would know, fundamentals are...
Analysis Article • Dec 13

Ergomed plc's (LON:ERGO) Intrinsic Value Is Potentially 20% Below Its Share Price

In this article we are going to estimate the intrinsic value of Ergomed plc ( LON:ERGO ) by taking the expected future...
Analysis Article • Nov 23

We Think Ergomed's (LON:ERGO) Statutory Profit Might Understate Its Earnings Potential

It might be old fashioned, but we really like to invest in companies that make a profit, each and every year. However...

Earnings and Revenue Growth Forecasts

AIM:ERGO - Analysts future estimates and past financials data (GBP Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20251992729337
12/31/20241802326307
12/31/20231612023267
6/30/2023152151719N/A
3/31/2023149151517N/A
12/31/2022145151315N/A
9/30/2022139141415N/A
6/30/2022132131516N/A
3/31/2022126131617N/A
12/31/2021119131819N/A
9/30/2021110121819N/A
6/30/2021102121718N/A
3/31/202194111718N/A
12/31/202086101718N/A
9/30/20208081617N/A
6/30/20207361617N/A
3/31/20207161314N/A
12/31/20196861112N/A
9/30/201966178N/A
6/30/201964-324N/A
3/31/201959-613N/A
12/31/201854-912N/A
9/30/201854-812N/A
6/30/201854-813N/A
3/31/201851-601N/A
12/31/201748-5-10N/A
9/30/201742-2-2-1N/A
6/30/2017360-4-2N/A
3/31/2017330N/A-2N/A
12/31/2016290N/A-2N/A
9/30/2016311N/A-2N/A
6/30/2016281N/A-2N/A
3/31/2016291N/A-1N/A
12/31/2015302N/A0N/A
9/30/2015291N/A1N/A
6/30/2015281N/A2N/A
3/31/2015241N/A1N/A
12/31/2014211N/A1N/A
9/30/2014191N/A0N/A
6/30/2014161N/A-1N/A
3/31/2014161N/A0N/A
12/31/2013152N/A1N/A
12/31/2012150N/A1N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: ERGO's forecast earnings growth (14.2% per year) is above the savings rate (1.5%).

Earnings vs Market: ERGO's earnings (14.2% per year) are forecast to grow faster than the UK market (10.3% per year).

High Growth Earnings: ERGO's earnings are forecast to grow, but not significantly.

Revenue vs Market: ERGO's revenue (8.8% per year) is forecast to grow faster than the UK market (4% per year).

High Growth Revenue: ERGO's revenue (8.8% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: ERGO's Return on Equity is forecast to be low in 3 years time (19.3%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2023/11/13 05:42
End of Day Share Price 2023/11/13 00:00
Earnings2023/06/30
Annual Earnings2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Ergomed plc is covered by 11 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Samuel EnglandBerenberg
Colin GrantDavy
Jonas PeciulisEdison Investment Research